Where does Galderma Research & Development rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Galderma Research & Development ranks #3,452 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Galderma Research & Development hold?

Galderma Research & Development holds 107 US utility patents granted between 2015 and 2023, spanning 33 technology areas.

What is Galderma Research & Development's Innovation Score?

Galderma Research & Development has an Innovation Score of 48.9 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Galderma Research & Development's patent grant rate increasing or decreasing?

Galderma Research & Development's recent grant velocity is -47% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Galderma Research & Development's patents?

Galderma Research & Development's patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Galderma Research & Development patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Galderma Research & Development

Q: What technology areas does Galderma Research & Development focus on?

Galderma Research & Development's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 84 patents. Grants appear in 33 CPC subclasses total.

USPTO PatentsView assignee record - 107 granted patents across 33 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Galderma ranks #3,452 of 49,997 tracked US assignees by granted-patent volume, with 107 patents across 33 technology areas.

#3,452
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.9/100): 18.5
avg claims per patent: -47%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3452 · Foreign Corporation #3,452 · 107 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 107 grants
TOP-DECILE #3,452/49,997
PHOTO-FINISH Costa Del Mar
CPC-FOCUS A61P · 33 areas
INNOV-PAR 48.9/100
CLAIMS-RICH 18.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -47% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Costa Del Mar, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cohere · near

49
Galderma Research &… · this assignee

49
Georgia-Pacific Gypsum · near

49
SiEn (QingDao)… · near

49
Vehicle Energy Japan · near

49
3D Lighting… · lowest

7

What this shows Galderma's Innovation Score is 48.9/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Galderma's grants concentrate

Galderma Research & Development is a focused PatentsView assignee: 33 CPC subclasses with 78.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (19 grants) versus a trough of 2 in 2023. By volume, Galderma sits between Costa Del Mar, Inc. and Ohio University.

Galderma's three-year grant acceleration

From 2019–2021 to 2022–2024, Galderma Research & Development moved from 41 to 8 grants (0.20x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,097. See the growth leaderboard.

Costa Del Mar

107
Cylance

107
Diebold Nixdorf I…

107
Elbit Systems

107
Jilin University

107
Mitsui High-tec

107
Nxgen Partners IP

107
Ohio University

107
Galderma Research… ◀

107

What this shows Galderma holds 107 patents at rank #3,452, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Galderma

By rank, the assignees closest to #3,452 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Galderma's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Galderma, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Cohere Technologies, Inc. 49 Vehicle Energy Japan Inc. 49 Georgia-Pacific Gypsum LLC 49 SiEn (QingDao) Integrated Circuits Co., Ltd. 49

Similar claim depth

Nearest assignees by average claims per patent (18.5 here).

CareFusion 2200, Inc. 18.5 avg Medicaroid Corporation 18.5 avg CAE Inc. 18.5 avg Ancestry.com Operations Inc. 18.5 avg

Galderma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Galderma Research & Development patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	18	16.8%
2016	19	17.8%
2017	9	8.4%
2018	12	11.2%
2019	12	11.2%
2020	18	16.8%
2021	11	10.3%
2022	6	5.6%
2023	2	1.9%

Which technologies does Galderma Research & Development patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 84

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 73

C07D - Heterocyclic Compounds 38

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 37

C07C - Acyclic OR Carbocyclic Compounds 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

Y02A - Technologies FOR Adaptation TO Climate Change 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 3

A61B - DIAGNOSIS; SURGERY; Identification 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 2

C07K - Peptides 2

Top 15 of 33 technology areas

Where it ranks

Overall rank by patents

#3,452

of 49,997 tracked assignees

Innovation Score

48.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Galderma Research & Development's patent record in context - here's where to go next.

Galderma Research & Development's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 78.5% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,452 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Galderma Research & Development against Costa Del Mar, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.